Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Mar;3(1):74-6.
doi: 10.3978/j.issn.2072-1439.2010.11.8.

Complication of warfarin therapy presenting as empyema

Affiliations
Case Reports

Complication of warfarin therapy presenting as empyema

Paresh Kumar Kuba et al. J Thorac Dis. 2011 Mar.

Abstract

A number of risk indices have been formulated in an attempt to predict risk of a major hemorrhage in an individual on warfarin therapy. No single index to date is able to reliably predict this risk in an individual patient. Although most warfarin related hemorrhages are gastrointestinal or intracranial in origin this case represents a particularly rare entity of a major hemorrhage presenting as an encysted empyema. To the best of our knowledge this has never before been described.

Keywords: empyema; hematology; lung; thoracotomy..

PubMed Disclaimer

Figures

Fig 1.
Fig 1.. Chest radiograph showing consolidation of the right middle and lower lobes and air fluid level in the right midzone.
Fig 2.
Fig 2.. Computerized tomography showing rounded opacity over the right mid-zone, pleural in origin.
Fig 3.
Fig 3.. Right middle and lower lobes exposed by posterlateral thoracotomy, revealing encysted collection and ecchymosis.
Fig 4.
Fig 4.. Evacuated right lower lobe collection and visceral pleura open.
Fig 5.
Fig 5.. Evacuated right middle lobe collection with visceral pleura open.

References

    1. Kucher N, Connolly S, Beckman JA, Cheng LH, Tsilimingras KV, Fanikos J, et al. International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. Arch Intern Med. 2004;164:2176–9. - PubMed
    1. Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160:1612–7. - PubMed
    1. Fitzmaurice David A, Blann Andrew D, Lip Gregory Y H. ABC of antithrombotic therapy. Bleeding risks of antithrombotic therapy. BMJ. 2002;325:828–31. - PMC - PubMed
    1. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105:91–9. - PubMed
    1. Kuijer PM, Hutten BA, Prins MH, Büller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med. 1999;159:457–60. - PubMed

Publication types